Skip to main content

Table 1 Baseline characteristics in the study group

From: Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire

Variable Results
Age(y), median (min, max) 58 (20–85)
Age at diagnosis (y), median (min, max) 53 (9–85)
Gender, n (%)  
 Male 52 (57%)
 Female 39 (43%)
Phenotype, n (%)  
 Obstructive 49 (54%)
 Nonobstructive 42 (46%)
NYHA class, n (%)  
 I 22 (24.2%)
 II 49 (53.8%)
 III 19 (20.9%)
 IV 1 (1.1%)
Systemic hypertension, n (%) 52 (61.9%)
Diabetes, n (%) 12 (14.3%)
Chronic Kidney disease, n (%) 21 (25%)
ICD, n (%) 7 (8.1%)
Pacemaker, n (%) 10 (11.6%)
Pulmonary hypertension, n (% of measured) 24 (34%)
Rhythm n (%)  
 Sinus rhythm 67 (73.6%)
 Atrial fibrillation 9 (9.9%)
 Other 15 (16.5%)
BNP (pg/ml), median (min,max) 296 (10–3999)
Coronary artery disease, n (%) 8 (12.1%)
  1. BNP brain natriuretic peptide, ICD implantable cardiac defibrillator, NYHA New York Heart Association, n number, y years